Stay updated on Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page.

Latest updates to the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page
- ChecktodayChange DetectedThe updated page uses a refreshed layout while keeping the same study details; no core study data changes are evident.SummaryDifference0.1%

- Check7 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. This is a minor version update with no changes to the study content.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. This indicates a minor version upgrade of the page content.SummaryDifference0.1%

- Check58 days agoChange DetectedUpdate adds Revision: v3.3.3 and removes the HHS Vulnerability Disclosure and Revision: v3.3.2 from the site footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page shows a software revision update from v3.2.0 to v3.3.2, with no changes to core study content or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page.